HC: Skip to main content

Media contact

Rolf Gulliksen

Rolf Gulliksen

Global Head of Corporate Communications

rolf.gulliksen@oncopeptides.com

+46 70 262 96 28

Events Oncopeptides

Upcoming events

Webcast - CHMP issues a positive opinion recommending full approval of Oncopeptides Pepaxti in EU

June 27, 2022 11:00 CET
Annual General Meeting 2022

June 28, 2022
Silent Period

July 12, 2022 - August 10, 2022
Interim report Q2 2022

August 11, 2022

Oncopeptides via e-mail

Get our latest updates straight to your inbox. Unsubscribe at anytime.